Filing Details

Accession Number:
0001501134-20-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-24 16:59:54
Reporting Period:
2020-11-20
Accepted Time:
2020-11-24 16:59:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627766 E Sean George C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-20 5,000 $8.70 643,376 No 4 M Direct
Common Stock Disposition 2020-11-20 1,100 $46.85 642,276 No 4 S Direct
Common Stock Disposition 2020-11-20 6,677 $48.08 635,599 No 4 S Direct
Common Stock Disposition 2020-11-20 906 $48.61 634,693 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2020-11-20 5,000 $0.00 5,000 $8.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,000 2024-10-15 No 4 M Direct
Footnotes
  1. Includes an aggregate of 226,598 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  2. The sale of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2020.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.53 to $47.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.53 to $48.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.53 to $48.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  6. The option was fully vested on 10/15/2018.